LSP (Life Sciences Partners), the leading life sciences investor in Europe, has recently announced that it has held its final close of LSP 6 at the $600 million (approx €530 million) hard cap. To date, this has been the largest fund ever raised in Europe focused on life sciences ventures.
With this funding, LSP currently has $1.1 billion (approx €965 million) of capital to invest across LSP 6, the LSP Health Economics Fund, and LSP’s public fund and mandates. Since 1988, LSP’s management has raised $2.5 billion (approx €2.2 billion) since it started to invest in the life sciences in 1988. The group has offices in Amsterdam, Munich, and Boston.